Efficacy and Safety Data (52-Week) from a Phase 1/2 Trial and Extension Study of JR-171 (lepunafusp Alfa) Used in Enzyme Replacement Therapy for Patients with MPS I
Molecular Genetics and Metabolism(2024)
关键词
Enzyme Replacement Therapy
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要